Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Breast Cancer (Female)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Early research (Phase 1)Study completedNCT00452673
What this trial is testing

Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Bristol-Myers Squibb 52
Testing effectiveness (Phase 2)Study completedNCT00645866
What this trial is testing

Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer

Who this might be right for
Breast Cancer
Mayo Clinic 47
Testing effectiveness (Phase 2)Study completedNCT00248404
What this trial is testing

NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)

Who this might be right for
Tumors
Kiadis Pharma 155
Testing effectiveness (Phase 2)Study completedNCT00066378
What this trial is testing

Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 71
Testing effectiveness (Phase 2)Ended earlyNCT01151215
What this trial is testing

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Who this might be right for
NeoplasmsBreast NeoplasmsBreast Cancer
AstraZeneca 482
Testing effectiveness (Phase 2)WithdrawnNCT00057993
What this trial is testing

Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
Northwestern University
Early research (Phase 1)Study completedNCT00096057
What this trial is testing

Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Jonsson Comprehensive Cancer Center 24
Early research (Phase 1)Study completedNCT02646748
What this trial is testing

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

Who this might be right for
Colorectal Cancer (CRC)Endometrial CancerMelanoma+8 more
Incyte Corporation 159
Not applicableStudy completedNCT00534274
What this trial is testing

Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving Chemotherapy

Who this might be right for
Breast Cancer
UNICANCER 97
Not applicableUnknownNCT01655004
What this trial is testing

Prospective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PD

Who this might be right for
Breast Carcinoma
National University Hospital, Singapore 110
Early research (Phase 1)Study completedNCT02262455
What this trial is testing

Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

Who this might be right for
Ovarian CancerFallopian Tube CancerEndometrial Cancer+1 more
Santa Maria Biotherapeutics 32
Testing effectiveness (Phase 2)UnknownNCT00687648
What this trial is testing

Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 70
Early research (Phase 1)Study completedNCT03775850
What this trial is testing

EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

Who this might be right for
Colorectal Cancer MetastaticTriple Negative Breast CancerNon Small Cell Lung Cancer+4 more
Evelo Biosciences, Inc. 69
Testing effectiveness (Phase 2)Study completedNCT00365417
What this trial is testing

Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 45
Large-scale testing (Phase 3)Study completedNCT00143390
What this trial is testing

Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 298
Testing effectiveness (Phase 2)Looking for participantsNCT05187338
What this trial is testing

Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors

Who this might be right for
Lung CancerLiver CancerColorectal Cancer+8 more
Second Affiliated Hospital of Guangzhou Medical University 100
Testing effectiveness (Phase 2)Study completedNCT02807844
What this trial is testing

Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies

Who this might be right for
Triple Negative Breast CancerPancreatic CarcinomaMelanoma+1 more
Novartis Pharmaceuticals 141
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)WithdrawnNCT00075413
What this trial is testing

Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
The University of Texas Medical Branch, Galveston
Next Page